Ozer Algan to Prospective Studies
This is a "connection" page, showing publications Ozer Algan has written about Prospective Studies.
Connection Strength
0.142
-
NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma. J Clin Oncol. 2023 02 20; 41(6):1285-1295.
Score: 0.040
-
A prospective single-institution study of intraoperative radiotherapy (IORT) for early-stage breast cancer. Breast J. 2021 03; 27(3):231-236.
Score: 0.035
-
Localization of the prostatic apex for radiation treatment planning. Int J Radiat Oncol Biol Phys. 1995 Nov 01; 33(4):925-30.
Score: 0.025
-
Management of adenocarcinoma of the esophagus with chemoradiation alone or chemoradiation followed by esophagectomy: results of sequential nonrandomized phase II studies. Int J Radiat Oncol Biol Phys. 1995 Jun 15; 32(3):753-61.
Score: 0.024
-
Surgical perspectives from a prospective, nonrandomized, multicenter study of breast conserving surgery and adjuvant electronic brachytherapy for the treatment of breast cancer. World J Surg Oncol. 2011 Mar 07; 9:30.
Score: 0.018